BioSpace News Archive

DURECT Corporation announced that James E. Brown, Chief Executive Officer, and Michael H. Arenberg, Chief Financial Officer, will be participating in the 20th Annual B. Riley FBR Institutional Investor Conference, taking place at the Beverly Hilton Hotel, Beverly Hills, CA May 22-23.

Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that two abstracts relating to the MANIFEST clinical trial of CPI-0610 for myelofibrosis – one in association with the American Society for Clinical Oncology (ASCO) annual meeting and the other in association with the European Hematology Association (EHA) annual meeting – published online.

Accenture (NYSE: ACN) today introduced INTIENT™, a technology platform that vastly improves the continuity and flow of data across life sciences enterprises, supporting the delivery of ground-breaking treatments for patients.

Christi Shaw, president of Lilly Bio-Medicines, will participate in a fireside chat at 9:30 a.m., Eastern Time.

New data on Opdivo (nivolumab) plus Yervoy (ipilimumab) in patients with advanced hepatocellular carcinoma and in melanoma patients with symptomatic brain metastases

DiaSorin Molecular LLC announced today that it has received CE marking for its new SimplexaTM HSV 1/2 & VZV Universal Direct assay.

ASCO (American Society of Clinical Oncology) has published the data obtained in the study of lurbinectedin (PharmaMar - MSE:PHM) as a single agent for the treatment of second line small cell lung cancer

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, today announces an update on trading for 2019

The world’s first ‘Darwinian’ drug discovery programme specially designed to tackle cancer’s lethal ability to evolve resistance to treatment is to be launched in a state-of-the-art new building in London.

The audited financial statements for the year ended December 31, 2018 included in the Annual Report on Form 10-K contained an audit opinion from its independent registered public accounting firm